Variable Susceptibility to Gallium Compounds of Major Cystic Fibrosis Pathogens.
antimicrobial susceptibility testing
cystic fibrosis
gallium maltolate
gallium nitrate
gallium protoporphyrin IX
Journal
ACS infectious diseases
ISSN: 2373-8227
Titre abrégé: ACS Infect Dis
Pays: United States
ID NLM: 101654580
Informations de publication
Date de publication:
14 01 2022
14 01 2022
Historique:
pubmed:
30
12
2021
medline:
27
1
2022
entrez:
29
12
2021
Statut:
ppublish
Résumé
The decreasing efficacy of existing antibiotics against pulmonary pathogens that affect cystic fibrosis (CF) patients calls for the development of novel antimicrobials. Iron uptake and metabolism are vital processes for bacteria, hence potential therapeutic targets. Gallium [Ga(III)] is a ferric iron-mimetic that inhibits bacterial growth by disrupting iron uptake and metabolism. In this work we evaluate the efficacy of three Ga(III) compounds, namely, Ga(NO
Identifiants
pubmed: 34965085
doi: 10.1021/acsinfecdis.1c00409
pmc: PMC8762661
doi:
Substances chimiques
Gallium
CH46OC8YV4
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
78-85Références
Arch Microbiol. 2020 Apr;202(3):617-622
pubmed: 31773196
Int J Environ Res Public Health. 2010 May;7(5):2337-61
pubmed: 20623028
N Engl J Med. 2015 Jan 22;372(4):351-62
pubmed: 25607428
J Med Microbiol. 2005 Jul;54(Pt 7):667-676
pubmed: 15947432
Antimicrob Agents Chemother. 2015 Aug;59(8):4826-34
pubmed: 26033732
Microbiology (Reading). 2004 Dec;150(Pt 12):3923-33
pubmed: 15583146
Mol Microbiol. 1999 Jan;31(2):429-42
pubmed: 10027961
Antimicrob Agents Chemother. 2015 Sep;59(9):5641-6
pubmed: 26149986
Int J Mol Sci. 2021 Mar 12;22(6):
pubmed: 33809032
Nat Rev Microbiol. 2012 Jul 16;10(8):525-37
pubmed: 22796883
J Clin Invest. 2007 Apr;117(4):877-88
pubmed: 17364024
Microbiol Spectr. 2016 Apr;4(2):
pubmed: 27227297
BMC Pulm Med. 2015 Jun 21;15:67
pubmed: 26093634
Pharmacol Rev. 1998 Dec;50(4):665-82
pubmed: 9860806
Front Cell Infect Microbiol. 2017 Jan 26;7:12
pubmed: 28184354
FEMS Microbiol Lett. 1997 May 1;150(1):19-26
pubmed: 9163901
Expert Opin Drug Discov. 2012 Sep;7(9):831-47
pubmed: 22812521
J Cyst Fibros. 2018 Nov;17(6):696-704
pubmed: 30266518
Diagn Microbiol Infect Dis. 2019 Aug;94(4):321-325
pubmed: 31029489
Microbiology (Reading). 2005 Nov;151(Pt 11):3749-3757
pubmed: 16272396
Sci Transl Med. 2018 Sep 26;10(460):
pubmed: 30257953
Biophys Chem. 2013 Oct-Nov;180-181:55-65
pubmed: 23838624
Pharmacol Res. 2017 Jan;115:56-64
pubmed: 27856328
Int J Antimicrob Agents. 2019 Jan;53(1):84-88
pubmed: 30240837
Antimicrob Agents Chemother. 2014 Sep;58(9):5572-5
pubmed: 24957826
Infect Immun. 1998 Oct;66(10):4733-41
pubmed: 9746572
Crit Rev Oncol Hematol. 2002 Jun;42(3):283-96
pubmed: 12050020
Molecules. 2018 Aug 16;23(8):
pubmed: 30115820
J Vis Exp. 2012 Jun 05;(64):e3857
pubmed: 22711026
Int J Med Microbiol. 2013 Dec;303(8):574-82
pubmed: 23992635
Pharmacol Res. 2021 Aug;170:105698
pubmed: 34058327
Future Microbiol. 2014;9(3):379-97
pubmed: 24762310
PLoS One. 2013 Aug 12;8(8):e71001
pubmed: 23951065
Infect Immun. 1987 Jan;55(1):148-53
pubmed: 3025098
J Clin Microbiol. 1993 May;31(5):1246-50
pubmed: 8501225
Biofactors. 2014 May-Jun;40(3):303-12
pubmed: 24532037
J Biol Inorg Chem. 2020 Dec;25(8):1153-1165
pubmed: 33125529
J Antimicrob Chemother. 2008 May;61(5):1062-5
pubmed: 18310047
Mol Microbiol. 2011 Apr;80(1):133-48
pubmed: 21276097
Front Cell Infect Microbiol. 2018 Sep 10;8:316
pubmed: 30250828
J Med Microbiol. 2017 Apr;66(4):490-501
pubmed: 28463663
ACS Infect Dis. 2019 Sep 13;5(9):1559-1569
pubmed: 31264851
Infect Immun. 2000 May;68(5):3007-9
pubmed: 10769004